Friend's E-mail:
 (maximum of 3 addresses separated by commas)
Your E-mail:
A Brief Comment (150 char max / 25 word max)
Article:

Albemarle to produce heart drug ingredient

BATON ROUGE, La. -- Albemarle Corp., a leading global provider of custom pharmaceutical manufacturing services, has entered into a manufacturing agreement with Anthera Pharmaceuticals in preparation for the Phase III clinical trial of Varespladib (A-002), a potential new, oral anti-inflammatory drug aimed at treating preconditions that can lead to heart disease.

Security image: (Case sensitive)
   

Note: the e-mail sent will contain information, such as your IP address (38.107.191.89), for purposes of tracking abuse. Use of this software to spam or harass individuals can and may result in penalties punishable by law.